Bifidobacterium
Also known as: Bifidobacteria, Bifidobacterium longum, B. infantis, B. lactis
The gut's first colonizers — the infant microbiome's foundation and a probiotic genus with strong IBS and gut-barrier evidence.
In short
Bifidobacterium is a genus of bacteria that dominates the healthy infant gut — babies born vaginally and breast-fed carry Bifidobacterium-rich microbiomes — and persists as a major adult gut group. As probiotics, specific strains are among the best-evidenced for digestive health: B. infantis 35624 has landmark trial data in irritable bowel syndrome, B. lactis (BB-12, HN019) has extensive evidence for gut regularity and immune support in children and adults, and bifidobacteria are a standard component of multi-strain formulas. Effects are strain-specific, and most evidence attaches to a handful of well-characterized commercial strains rather than the genus as a whole.
- Dominant genus of the healthy infant gut microbiome
- B. infantis 35624: landmark IBS trial evidence
- BB-12 and HN019: gut regularity and immune evidence
- Strain-specific effects — check the strain designation
What is Bifidobacterium?
Bifidobacterium is the genus that builds the human gut from day one. Breast-fed infants run on bifidobacteria — the milk oligosaccharides in human milk exist largely to feed them — and a healthy adult gut still keeps billions. That biological centrality is why the genus dominates probiotic research: B. infantis 35624 produced one of the strongest-ever IBS trial results, and B. lactis strains like BB-12 and HN019 anchor immune and regularity claims across ages. The genus-level name is only the start, though — bifidobacteria are a family of specialists, and the strain code is the product.
Where it comes from
Natural sources
- Gram-positive anaerobic bacteria; dominant in infant gut from vaginal birth and breast milk
- Present in fermented dairy; dozens of commercial strains isolated
- Key commercial strains: B. infantis 35624, B. lactis BB-12, HN019, B. longum
How it's made
Lyophilized in capsules, powders, drops, and fortified dairy; counts from 1–100 billion CFU.
What it does in products
Benefits
IBS symptom relief
strong evidenceB. infantis 35624 improved global IBS symptoms, pain, and bloating in landmark randomized trials — among the strongest single-strain probiotic results for IBS.
Gut regularity
strong evidenceB. lactis strains (BB-12, HN019) improve stool frequency in adults with slow transit and prevent constipation in trials.
Immune support in children and adults
moderate evidenceTrials show fewer respiratory infections and improved vaccine responses with specific bifidobacteria strains, particularly BB-12 and HN019.
Side effects & safety
Safety considerations
- Well tolerated in trials, including pregnancy; standard probiotic caution applies for severely immunocompromised individuals.
- Antibiotics — separate by 2+ hours
- Immunosuppressants — seek medical advice before any live probiotic
- Not for: Severe immunocompromise
- Not for: Short-gut syndrome
How it's used
In supplements
1–10 billion CFU/day for maintenance; IBS trials with 35624 used 1 billion CFU/day (10⁸). Higher counts (10–100 billion) used for recovery phases.
In skincare
Not a topical ingredient.
Regulatory status
- Sold as a dietary supplement; GRAS status for specific strains in infant formula and foods.
- GRAS (generally recognized as safe) for food use.
- Not applicable.
Popular products containing Bifidobacterium
- Align Probiotic (B. infantis 35624) — The landmark IBS strainAlign · Supplement
- Culturelle Kids / BB-12 products — Bifidobacteria-containing formulasCulturelle · Supplement
- Garden of Life Dr. Formulated Once Daily — Multi-strain with bifidobacteriaGarden of Life · Supplement
Product names and brands are shown for reference and belong to their respective owners.
Why bifidobacteria matter from birth
Human milk oligosaccharides are indigestible by babies but fermented by Bifidobacterium — an evolutionary pact in which mothers feed their infants' first gut microbes. Bifidobacteria then train the immune system and outcompete pathogens. This foundational biology explains the genus's prominence in infant formula and pediatric probiotic research.
The IBS evidence
The B. infantis 35624 story is a case study in strain specificity: in a 2006 trial, IBS patients taking the strain showed global symptom improvement versus placebo, with normalization of inflammatory cytokine ratios. Follow-ups confirmed efficacy at 10⁸ CFU/day. Other bifidobacteria strains do not automatically share this data.
Frequently asked questions
Which Bifidobacterium strain is best for IBS?
B. infantis 35624 (Align) has the strongest single-strain IBS evidence. Multi-strain blends containing bifidobacteria also perform well in trials, but check for strain specificity.
Should babies take bifidobacteria?
Specific strains (BB-12, HN019) have pediatric trial support for colic, diarrhea, and eczema risk in some studies. Use pediatric formulations and consult a pediatrician.
Do bifidobacteria need refrigeration?
Some strains are shelf-stable, but refrigeration preserves viability. Follow label storage instructions.
The bottom line
Bifidobacterium is the foundation genus of the human gut microbiome, and its best-characterized strains deliver real, strain-specific evidence — from IBS relief to immune support.
References
- Bifidobacterium infantis 35624 in irritable bowel syndrome. Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/17053136/
- Probiotics — Health Professional Fact Sheet. NIH Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
- Bifidobacterium lactis BB-12: clinical evidence review. PubMed Central. https://pubmed.ncbi.nlm.nih.gov/30305045/